Genmab A/S (ETR:GE9)
271.10
-10.10 (-3.59%)
At close: Oct 10, 2025
Genmab Market Cap
Genmab has a market cap or net worth of €16.85 billion as of October 10, 2025. Its market cap has increased by 23.04% in one year.
Market Cap
16.85B
Enterprise Value
14.51B
Revenue
3.11B
Ranking
n/a
PE Ratio
14.44
Stock Price
€271.10
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 485.53M to 16.85B, an increase of 3,371.22%. That is a compound annual growth rate of 15.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 16.85B | 32.53% |
Dec 30, 2024 | 12.72B | -32.67% |
Dec 29, 2023 | 18.89B | -26.92% |
Dec 30, 2022 | 25.84B | 11.67% |
Dec 30, 2021 | 23.14B | 6.90% |
Dec 30, 2020 | 21.65B | 67.74% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 268.50B |
Siemens Aktiengesellschaft | 187.82B |
Deutsche Telekom AG | 141.42B |
Allianz SE | 139.73B |
Siemens Energy AG | 90.31B |
Rheinmetall AG | 86.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 72.92B |
Deutsche Bank Aktiengesellschaft | 57.47B |